2022. Interleukin 22 (IL-22) As Biomarker For Rheumatoid Arthritis In Iraqi Population. Journal of Pharmaceutical Negative Results. (Oct. 2022), 209–212. DOI:https://doi.org/10.47750/pnr.2022.13.S02.29.